Skip to content
flibanserin

Structure via PubChem · Public domain (PubChem)

EntityQ415996· pop 22· linked from 1,723 articles

flibanserin

Sign in to save

Also known as Addyi®, BIMT-17, Girosa® (proposed trade name), 1-(2-(4-alpha,alpha,alpha-Trifluoro-m-tolyl)-1-(piperazinyl)ethyl)-2-benzimidazolinone, Female Viagra (Street Name), Bimt 17, 1,3-Dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2H-benzimidazol-2-one, BIMT 17 BS

Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication attempts to improve sexual desire, increase the number of satisfying sexual events, and decrease the distress associated with low sexual desire. The most common side effects are dizziness, sleepiness, nausea, difficulty falling asleep or staying asleep and dry mouth.

Key facts

Drug.PubChem
6918248
Drug.UNII
37JK4STR6Z
Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.verifiedrevid
437139289
Drug.image
Flibanserin.svg
Drug.image_class
skin-invert-image
Drug.image2
Flibanserin ball-and-stick model.png
Drug.image_class2
bg-transparent
Drug.tradename
Addyi
Drug.MedlinePlus
a615040
Drug.DailyMedID
Flibanserin
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
G02
Drug.ATC_suffix
CX02
Drug.legal_US
Rx-only
Drug.bioavailability
33%
Drug.protein_bound
~98%

via Wikipedia infobox

Chemical data

Formula
C20H21F3N4O
Molecular weight
390.4 g/mol
IUPAC name
3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one
SMILES
C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F
InChIKey
PPRRDFIXUUSXRA-UHFFFAOYSA-N
XLogP
3.3
Polar surface area
38.8 Ų
H-bond donors
1
H-bond acceptors
6
Formal charge
0

via PubChem

Research

274 papers

via PubMed

Wikidata facts

Mass
390.167
Show 4 more facts
chemical formula
C₂₀H₂₁F₃N₄O
canonical SMILES
C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F
World Health Organisation international non-proprietary name
flibanserin
Commons category
Flibanserin
Sources (4)

via Wikidata · CC0

~13 min read

Article

13 sections
Contents
  • Medical uses
  • Side effects
  • Mechanism of action
  • Activity profile
  • Society and culture
  • Names
  • Approval process and advocacy
  • Advocacy groups
  • Acquisition by Valeant Pharmaceuticals
  • Reception
  • References
  • Further reading
  • External links

{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 437139289 | image = Flibanserin.svg | image_class = skin-invert-image | alt = | image2 = Flibanserin ball-and-stick model.png | image_class2 = bg-transparent | alt2 =

| pronounce = | tradename = Addyi | Drugs.com = | MedlinePlus = a615040 | DailyMedID = Flibanserin | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = G02 | ATC_suffix = CX02

Connections

Categories